Vials Market Size, Share, Opportunities, And Trends By Capacity (Up to 2 ml, 3 ml – 5 ml, 5 ml – 7 ml, 8 ml and above), By Material (Glass (Borosilicate glass, Fused Silica), Plastic (Thermoplastics (HDPE, Poly Vinyl Chloride, Polycarbonate, Polypropylene), Thermosets (Melamine Formaldehyde, Phenol-Formaldehyde, Poly Urea Formaldehyde, Others)), By Filling Technology (Net weight fillers, Rotary fillers, Volumetric fillers, Others), By End-User (Personal Care, Chemicals. Healthcare, Hospitals, Pharmaceuticals, Research Laboratories), And By Geography - Forecasts From 2025 To 2030

Vials Market Size:

The Vials Market is expected to grow from USD 12.058 billion in 2025 to USD 15.915 billion in 2030, at a CAGR of 5.71%.

Vials are used in a variety of fields, including biotechnology, life sciences, chemicals, personal care, healthcare, food and beverage, pesticides, and insecticides. Among all the applications, the one that is common to almost every aspect that human lives interact with is that of biotechnology. Whether it's pharmaceuticals, molecular gastronomy, or agriculture (to name a few), the role of biotechnology is ubiquitous.

This is palpable by the rate of investments that take place throughout any given financial year in various nations between various stakeholders. To this end, it may be noted that ARCH Venture Partners increased its funding by $1.46 billion to support new tech development. Just to provide a bit more insight into the aforesaid ARCH portfolio companies, Vir Biotechnology, Alnylam Pharmaceuticals, VBI Vaccines, Brii Biosciences, and Sana Biotechnology are all working on COVID-19 therapeutics. Furthermore, to support clinical testing and clinical trial development, Quanterix is developing a relevant technology. Twist Biosciences is another company that has gene-editing tools that the company believes can support therapeutic and vaccine development that has been backed by ARCH. Another entity, Bellerophon, received emergency access approval from the FDA because of being the developer of inhaled nitric oxide delivery technologies that possess the capability to be used as a treatment to treat the distress associated with COVID-19.Conagen’s synthetic biology research and development which is geared towards contributing to a clean and sustainable planet will be propelled by this investment.

The objective of this investment is to materialize the shared vision of bio-designing and making sustainable green chemicals available in the market, ultimately reducing the global chemical footprint and making the environment safer.  Thus, with avid interests among various stakeholders along with the exigencies of the pandemic as well as other pressing matters that cause immense stress on the global ecosystems, R&D investments not only related to biochemistry as exemplified above but also a host of other scientific fields will be set in motion during the forecast period, thereby necessitating the utilization of various types of vials, which in turn is expected to fuel the vial market during the forecast period and beyond.

Vials Market Growth Drivers:

• The favourable government policies that are facilitating impact investment and other mechanisms that are aimed at the plausible alleviation of various issues are further expected to promote market growth.

For example, 3.5 percent of the gross domestic product (GDP) has been set aside for R&D by 2025 [Source: The Federal Funding Advisory Service for Research and Innovation]. With regards to India, the Department of Biotechnology (DBT) under the Ministry of Science and Technology, Government of India jointly with the Indian Council of Medical Research (ICMR), formulated and made amendments to the National Guidelines for Stem Cell Research. As per the recommendation of the inter-ministerial meeting, "National Guidelines for Stem Cell Therapy" is also being formulated jointly with ICMR and other stakeholders. A total of 47 collaborative projects have been recommended for funding support in the above three areas. Thus, with such aforesaid exemplification of government interventions, the facilitation of biotechnological among others will even more emphatically which will increase the demand for vials, the inseverable component of any research lab around the world.  As a result, the Vials market is expected to grow during the forecast period

• Concomitant to the technological front, the boom in personal care products and the inclusion of phytochemicals whose end products are sold as nutraceuticals are also poised to drive the growth of the vial market.

This demand stems from the increasingly health-conscious urbanites who are keener on doing away with for example skincare products that contain harmful chemicals. Further, unemployed unindividual whose disposable income has increased during recent years aspire to products that are above premium quality products, and the basket now increasingly includes more products from the luxury segment. This development is causing market players in various segments to increase and expand their product portfolios in order to attract new customers and retain existing ones. Therefore, this increases the demand for vials that not only find their application in product development but also are purchased off the shelf of the store containing a particular product. This propelled the demand for vials during the forecast period.

Segmentation

• By Capacity
  • Up to 2 ml
  • 3 ml – 5 ml
  • 5 ml – 7 ml
  • 8 ml and above
• By Material
  • Glass
    • Borosilicate glass
    • Fused Silica
  • Polymer
  • Plastic
    • Thermoplastics
      • HDPE
      • Poly Vinyl Chloride
      • Polycarbonate
      • Polypropylene
    • Thermosets
      • Melamine Formaldehyde
      • Phenol Formaldehyde
      • PolyUrea Formaldehyde
      • Others
• By Filling Technology
  • Net weight fillers
  • Rotary fillers
  • Volumetric fillers
  • Other fillers
• By End User
  • Personal Care
  • Chemicals
  • Healthcare
  • Hospitals
  • Pharmaceuticals
  • Research Laboratories
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Others
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. VIALS MARKET BY CAPACITY

5.1. Introduction

5.2. Up to 2 ml

5.3. 3 ml – 5 ml

5.4. 5 ml – 7 ml

5.5. 8 ml and above

6. VIALS MARKET BY MATERIAL 

6.1. Introduction

6.2. Glass

6.2.1. Borosilicate glass

6.2.2. Fused Silica

6.3. Polymer

6.4. Plastic

6.5.1. Thermoplastics

6.5.1.1. HDPE

6.5.1.2. Poly Vinyl Chloride

6.5.1.3. Polycarbonate

6.5.1.4. Polypropylene

6.5.2. Thermosets

6.5.2.1. Melamine Formaldehyde

6.5.2.2. Phenol Formaldehyde

6.5.2.3. PolyUrea Formaldehyde

6.5.2.4. Others

7. VIALS MARKET BY FILLING TECHNOLOGY

7.1. Introduction

7.2. Net weight fillers

7.3. Rotary fillers

7.4. Volumetric fillers

7.5. Other fillers

8. VIALS MARKET BY END-USER

8.1. Introduction

8.2. Personal Care

8.3. Chemicals

8.4. Healthcare

8.5. Hospitals

8.6. Pharmaceuticals

8.7. Research Laboratories

9. VIALS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Italy

9.4.6. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. Taiwan

9.6.5. Thailand 

9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Amcor plc 

11.2. Gerresheimer AG 

11.3. SCHOTT AG 

11.4. West Pharmaceutical Services, Inc. 

11.5. Becton, Dickinson and Company 

11.6. AptarGroup, Inc. 

11.7 Corning Incorporated

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

Amcor plc

Gerresheimer AG

SCHOTT AG

West Pharmaceutical Services, Inc.

Becton, Dickinson and Company

AptarGroup, Inc.

Corning Incorporated